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A world with inevitably limited resources requires 
prioritization of those resources and the arena of 
public health is no exception. As the world faces 
unprecedented numbers of older adults and levels 
of noncommunicable disease (NCD),1 there has 
been an increased orientation towards strategies 
for risk reduction, NCD prevention2 and effective 
ways to support healthy ageing.3 The most recent 
NCD area to rise to prominence, partly due to 
our ageing population, is dementia.4 The last 20–
30 years has seen an exponential rise in research 
on the identification and understanding of 
dementia risk factors. This began with investiga-
tion of single risk factors, for example,5–7 clinical 
trials8–10 and evidence synthesis,11–13 most recently 
moving towards a developing understanding of 
the impact of multiple co-occurring risk factors14 
and multifactorial risk reduction.15–17
In 2016, dementia also appeared for the first time 
as one of five NCDs ranked in the World Health 
Organization (WHO) top 10 causes of death 
globally alongside other NCD categories, coro-
nary heart disease (CHD), stroke, diabetes mel-
litus (DM) and cancers.18 When evaluated across 
lower-, middle- and high-income economies, 
CHD and stroke maintain their places consist-
ently within the top five causes of death and top 
causes of NCD-related death. DM is present in 
all but the lowest income category and dementia 
is within the top five causes of death in 
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upper-middle- and high-income countries. 
Amongst the cancers, trachea, bronchus and 
lung, liver and stomach, colon and rectum and 
breast cancers also ranked within the top 10 
causes of death in upper-middle- and high-
income countries in 2016.18 Importantly, demen-
tia and other NCDs, such as CHD, share more 
than their ranking in the WHO top 10 causes of 
death. They are also characterized by multiple 
overlapping lifestyle and clinical risk factors (for 
example, obesity, physical inactivity, high blood 
pressure), acting singly or together to increase 
risk, and may all benefit from risk reduction 
efforts.19–22 Depression, diabetes or impaired glu-
cose tolerance, high cholesterol, high blood pres-
sure, obesity, unhealthy diet, smoking, physical 
inactivity and excess alcohol consumption have 
been identified by the WHO Global Health 
Observatory data as common and preventable 
risk factors that underlie most NCDs.23 Increasing 
evidence also points to air pollution as an emerg-
ing risk factor for dementia, heart and cardiovas-
cular disease and lung cancer.1,14
To more accurately model the influence of risk fac-
tor prevalence and risk factor modification on inci-
dent disease and health outcomes, and to effectively 
target risk reduction strategies, we now need to 
understand the overlap between risk factors and the 
main NCDs. The aim of this systematic overview 
of reviews was to identify and evaluate the evidence 
for overlapping risk factors between dementia, 
DM, CHD, stroke and selected cancers.
Methods
We completed a detailed systematic overview of 
reviews.24 That is, we reviewed published overviews 
and reviews reporting on one or more common risk 
factors and one or more of the NCD categories, 
dementia, DM, CHD, stroke and selected can-
cers. A written protocol was registered with the 
International Prospective Register of Systematic 
Reviews (PROSPERO; CRD42019129265) and 
the review was reported in accordance with the 
Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses (PRISMA) checklist.25
The Cochrane Database of Systematic Reviews, 
and Ovid MEDLINE were searched from 
inception to 1 March 2019. The following NCD 
keywords were used: dementia, Alzheimer’s (or 
Alzheimer or Alzheimers) disease, diabetes, 
ischaemic (or ischemic) heart disease, coronary 
artery disease, coronary heart disease, myocar-
dial infarction, stroke, cancer, together with the 
following keywords for the nine common risk 
factors: depression, cholesterol, hypertension, 
obesity, diet, smoking, physical activity, alcohol 
or air pollution. Supplementary text file 1 pro-
vides full details of the search terms. Additional 
data sources included a review of guidelines pub-
lished by the WHO, the UK National Institute 
for Health and Care Excellence, systematic 
reviews commissioned by the Agency for 
Healthcare Research and Quality and expert 
recommendation.
Given the volume of data in this area and the 
need to include the most up-to-date evidence 
synthesis, we used a pragmatic selection method, 
adapted from guideline development methodol-
ogy, selecting the most comprehensive and recent 
evidence sources.26 To achieve this we selected 
published overviews or reviews (sometimes 
referred to as umbrella reviews) or, where these 
were unavailable, single systematic reviews. We 
selected the most recently published review in 
each area first examining those published within 
the last 5 years and only looking at earlier litera-
ture where recent publications were not available. 
If two publications were available from the same 
year, the publication with the most recent search 
dates was used. Reviews were required to report 
meta-analyses of prospective studies reporting an 
association between one or more of the nine 
selected risk factors and one or more of the 
selected incident NCDs. Established and preva-
lent risk factors were selected (based on those rec-
ognized by the WHO www.who.int/healthinfo/
global_burden_disease/global_health_risks/en) to 
include depression, high cholesterol, high blood 
pressure, obesity, diet (whole dietary pattern), 
smoking, physical inactivity, excess alcohol con-
sumption or air pollution). The NCDs included: 
dementia [all-cause or Alzheimer’s disease (AD) 
or vascular dementia (VaD)], DM, CHD (defined 
as coronary artery disease, ischaemic heart dis-
ease or myocardial infarction), stroke (ischaemic 
or haemorrhagic) or cancer (of all types or of the 
lung, liver, bowel or breast in accordance with the 
cancer types featured in the WHO top 10 causes 
of death).18 Meta-analyses of prospective longitu-
dinal cohort studies were selected to provide the 
most robust information on relationships between 
risk factor exposure and disease development. 
Cross-sectional and case-control studies were 
excluded because they do not provide sufficiently 
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robust data with regard to the evaluation of cau-
sality between risk factors and disease outcomes. 
Furthermore, clinical trials were not included, as 
the focus of this research was on the relationship 
between risk factors and disease rather than on 
risk reduction. We also excluded nonsystematic 
reviews, narrative reviews, reviews focusing solely 
on dietary constituents, as opposed to whole diet 
and reviews including studies conducted in sec-
ondary prevention populations (i.e. in popula-
tions that already have one of the five selected 
NCD outcomes). The varied source data also 
meant that it was not possible to statistically syn-
thesize the data nor to fully take subgroups, such 
as the age of risk factor exposure, into account; 
however, where differing results were reported 
from broad subgroups such as mid/late-life, pre/
postmenopausal women, these are reported.
All titles were screened for relevance. Those 
that were selected as relevant, progressed to 
abstract screening by two independent reviewers. 
Disagreement between reviewers was resolved by 
discussion and further full-text screening took 
place, with disagreement similarly resolved by 
discussion. Data extraction was completed by one 
reviewer and checked by a second independent 
reviewer. Data on key population and demo-
graphic information, risk factor classification, 
outcome identification and pooled values for the 
associations between risk factors and outcomes 
were extracted into an a priori designed extraction 
table. Reviews were assessed for bias using the 
revised instrument, AMSTAR-2 (A MeaSurement 
Tool to Assess systematic Reviews 2) criteria.27
Results
Searching and expert recommendation resulted 
in 1374 unique records. There were 1173 records 
rejected at the title screening stage for not report-
ing results for overview or single systematic 
reviews relevant to the selected risk factors and 
NCD categories. The remaining 201 articles were 
screened at abstract stage, 125 were rejected and 
76 were examined at full-text screening (Figure 
1). A further 49 articles12,13,28–74 were rejected at 
the full-text stage, primarily due to their relative 
redundancy given the availability of a more recent 
review or more current search dates. Overall, nine 
of these articles38,44–47,58,62,63,68 were excluded due 
to reasons such as nonstandard or inappropriate 
exposure or outcome measures, data derived from 
only one cohort study or unclear methodology 
(Supplementary Table 4 and supplementary ref-
erence list), leaving 27 reviews11,14,75–99 to be 
included.
Of the 27 publications selected for inclusion, 5 
were overview reviews and 22 were single system-
atic reviews. All but one review78 were published 
within the last 5 years. From these 27 articles, 89 
relevant unique meta-analyses and 1 systematic 
review, with a figurative rather than statistical for-
est plot summarizing the data, were examined 
and extracted (Supplementary Table 1). Overall 
data on risk factors and dementia, DM, CHD 
and stroke was reasonably comprehensive. No 
reviews reported on the relationship between dia-
betes and cholesterol, diabetes and alcohol, CHD 
and smoking, stroke and depression, and of the 
five NCD categories, the least data were available 
for cancer (Table 1). Table 1 shows the extent of 
the evidence and the direction of the reported 
relationships between the risk factors and NCD 
disease outcomes.
The most consistent and comprehensive evi-
dence was available for diet and physical activity. 
High adherence to a Mediterranean diet was 
shown to reduce risk across all five NCDs by 
between 4% and 36%,11,77,90,93,98 and higher lev-
els of physical activity similarly resulted in risk 
reduction of between 13% and 45%.11,75,77,94 
The detrimental effects of smoking and obesity 
were also evident from available data. Smoking 
was associated with an increased risk of AD, any 
dementia, VaD, DM, stroke, and lung, bowel 
and breast cancer with increased risk 
estimates variously reported between 9% and 
633%.11,77,78,87,89,95 Obesity was associated with 
an increased risk of AD, DM, CHD, stroke and 
liver and bowel cancer by between 33% and 
588%.11,77,81,85 Obesity may also increase the risk 
of breast cancer in postmenopausal women.85 
No association was found between obesity and 
VaD11 and an anomalous protective effect was 
found for lung cancer that was reported to be 
derived from a small sample of heterogeneous 
studies.85 High blood pressure was associated 
with a 7–75% increased risk of VaD, DM, CHD, 
stroke and breast cancer,11,77,83,84,96 but no asso-
ciation was found for AD.11 The evidence for 
excess alcohol consumption was the least con-
sistent across the NCDs, with three meta-analy-
ses showing significant associations with 
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Figure 1. PRISMA flow chart.
PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses
increased risk and six showing no association. 
Excess alcohol consumption was associated with 
an increased risk of stroke, bowel and breast 
cancer (between 20% and 50%).11,76,97 However, 
no association was found between excess alcohol 
consumption and the dementias,11 CHD,91 
lung76 or liver cancer.99
Whilst less evidence was available for the 
remaining risk factors, broad associations were 
reported between air pollution and an increased 
risk of dementia,14 DM,77 stroke,92 lung can-
cer82 and CHD.79 Depression was found to be 
associated with an increased risk of AD, any 
dementia, DM and CHD by between 30% and 
104%,11,77,80 but had no effect on VaD risk.11 
High cholesterol was associated with a 20–24% 
increased risk of CHD11 and (when present in 
midlife) was associated with a doubling in the 
risk of AD88 but had no effect on any dementia, 
VaD11 or stroke.86 Whilst the current data are 
insufficient to allow the building of a structural 
equation model, the complexity and overlaps 
within these relationships can be shown dia-
grammatically, see Figure 2. Figure 2 also pro-
vides additional contextual information, beyond 
the scope of this review, by highlighting the 
potential further relationships between the risk 
factors themselves and between NCD catego-
ries. For example, poor diet and lack of physical 
activity may increase risk of obesity with conse-
quent increased risk of hypertension, and stroke 





























Table 1. Showing the direction of relationships and extent of the systematic review and meta-analysis evidence for the associations between the selected risk 
factors and noncommunicable diseases.
Dietary pattern Physical 
activity
Smoking Air pollution High blood 
pressure
















. ↑ Anstey and 
colleagues11
↑↑ Anstey and 
colleagues11
≠ Anstey and 
colleagues11
≠ Anstey and 
colleagues11
↑↑ NO2, NOx 
Peters and 
colleagues14
≠ Late life Anstey and 
colleagues11





↑↑ Anstey and 
colleagues11
. ≠ Anstey 
and 
colleagues11
↑↑ Anstey and 
colleagues11
↑↑ Anstey and 
colleagues11
↑↑ Mid life 
Anstey and 
colleagues11
≠ Anstey and 
colleagues11
 ≠ Late life 
Anstey and 
colleagues11
VaD . ↓↓ Anstey 
and 
colleagues11
↑↑ Anstey and 
colleagues11
 . ↑↑ Anstey 
and 
colleagues11
≠ Anstey and 
colleagues11
≠ Anstey and 
colleagues11
≠ Late life 
Anstey and 
colleagues11
≠ Anstey and 
colleagues11





↑↑ Bellou and 
colleagues77





↑↑ Bellou and 
colleagues77
↑↑ Bellou and 
colleagues77
. .
Stroke ↓↓ Psaltopoulou 
and colleagues90
↓↓ Wahid and 
colleagues94
↑↑ Peters and 
colleagues89





↑↑ Global Burden of 
Metabolic Risk Factors 
for Chronic Diseases 
Collaboration and 
colleagues81
. ≠ Lindbohm 
and 
colleagues86
↑↑ Zhang and 
colleagues97
CHD ↓↓ Galbete and 
colleagues98
↓↓ Wahid and 
colleagues94
. ↑↑ PM10 
Cesaroni and 
colleagues79
↑↑ Wei and 
colleagues96
↑↑ Global Burden of 
Metabolic Risk Factors 
for Chronic Diseases 
Collaboration and 
colleagues81
↑↑ Gan and 
colleagues80
↑↑ Peters and 
colleagues88
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activity
Smoking Air pollution High blood 
pressure
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↑↑ Wang and 
colleagues95





. . ↑↑ Bagnardi 
and colleagues76









↑↑ Botteri and 
colleagues78
. . ↑↑ Kygriou and 
colleagues85
. . ↑↑ Bagnardi 
and colleagues76
Lung . ↓↓ de 
Rezende and 
colleagues75





↓↓ Kygriou and 
colleagues85






Liver . . . . . ↑↑ Kygriou and 
colleagues83,85
. . ≠ Turati and 
colleagues99
↑↑, denotes probable positive association; ↓↓, denotes probable negative association; ↑, denotes possible positive association (meta-analyses show mixed but generally positive outcomes); ↓, denotes 
possible negative association (meta-analyses show mixed but generally negative outcomes); ≠, denotes no association found; ., denotes no review identified.
AD, Alzheimer’s disease; CHD, coronary heart disease; DM, diabetes mellitus; PM, particulate matter.
Table 1. (Continued)
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Overall, probable or possible associations were 
observed between all risk factors and at least two 
of the five NCDs. The strongest protective fac-
tors were healthy diet and physical activity, which 
were shown to impact risk across all five NCDs. 
Air pollution was linked to all five NCDs with the 
strongest evidence for fine particle (PM2.5) expo-
sure. Depression, high blood pressure and obesity 
were linked to all the NCDs for which there was 
available data, with some variability amongst 
dementia and cancer subtype.
Quality rating
The AMSTAR-2 was employed to assess the qual-
ity of selected reviews. Of the 27 included publica-
tions, 11 (41%) were characterized as critically low 
quality, 12 (44%) of low quality and 4 (15%) of 
moderate quality (Supplementary Table 2).
Discussion
Summary of findings
Both healthy dietary pattern and physical activity 
were consistently associated with reduced risk 
across the NCD categories,11,75,77,90,93,94,98 and a 
comprehensive body of evidence substantiated 
these findings. Smoking and air pollution 
were also associated with increased risk of inci-
dent NCDs,11,14,77–79,82,87,89,92,95 and to a lesser 
extent, so were high blood pressure and obe-
sity.11,77,81,84,85,96 The evidence for depression and 
high cholesterol was suggestive of increased risk 
Figure 2. Diagram showing the reported relationships between established risk factors and NCDs.
NCD, noncommunicable disease.
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for the cardiovascular rather than the cancer out-
comes,11,77,80,86,88 with the weakest evidence for 
alcohol as a common risk factor.11,76,91,97,99
Strengths and limitations
The strengths of our review include the use of a 
pragmatic high-level but systematic overview of 
reviews strategy. This has allowed us to deliver a 
broad evidence-based overview, drawing together 
information on the relationships between preva-
lent NCD and common risk factors. This has 
been further facilitated by the recent rise in pub-
lished overview and single systematic reviews 
examining single disease or single risk factors. 
The global ageing population, rising prevalence 
of concomitant lifestyle and NCD risk factors and 
disease also make research across common NCDs 
both timely and important. Our review is an 
essential step towards a greater public health 
understanding of the interacting relationships 
driving NCDs. It has allowed us to document and 
highlight the overlapping risk factors and will help 
direct future work in this area.
Limitations inherent in drawing together existing 
reviews, and in particular overview reviews, inevi-
tably include the risk of propagating existing bias. 
This may include selection bias driven by the 
inclusion of particular participants in cohort stud-
ies, inclusion of particular cohort studies or cohort 
study results in systematic reviews and meta- 
analyses and the inclusion of particular reviews in 
overview reviews. As in any review, further bias 
may come from drawing together varied reporting 
of results, analytical approaches, assessment of risk 
factor exposure, accounting for confounders and 
the possibility of reporting error. The AMSTAR-2 
assessment tool, although the most appropriate, is 
not designed to assess overview reviews and, in 
part due to its rigour, is likely to assess anything 
other than very recent reviews as lower quality. 
Bias in overview reviews may also come from the 
age of the constituent studies with older studies 
potentially included in greater numbers of meta-
analyses, and possibly also of lower quality. Our 
methods too, while systematized, may be a source 
of bias. Overall our review process was pragmatic 
and rigorous but inevitably open to bias. Taking a 
top-level focus and using existing reviews and 
meta-analyses meant that we were able to review a 
wide area but were unable to statistically synthesize 
the evidence or revisit the original cohort studies or 
participant level data where (1) evidence although 
present, might feature only to a lesser degree, for 
example for AD and hypertension, or (2) where 
risk relationships are long established and meta-
analyses may never have been performed, for 
example smoking and CHD. Caution also needs 
to be applied where constituent studies were 
themselves rated poorly in terms of risk of bias. 
Furthermore, in taking a pragmatic approach to 
the classification of NCDs we may have missed 
some subtleties in the varied cancer diagnoses and 
inadvertently introduced a false level of certainty 
with regard to dementia type where overlapping 
pathology, rather than definitive diagnosis, is 
acknowledged as the most common occurrence.102 
Finally, for dementia at least, there is some evi-
dence that age of exposure to the different risk fac-
tors may moderate their impact103–105 and we were 
unable to take this into account. Nevertheless, our 
findings are consistent in showing the complexity 
and overlap of the relationships in this area.
Implications and research recommendations
Although our results suggest that exposure to indi-
vidual risk factors may act to concurrently raise the 
risk of more than one NCD we did not find suffi-
cient evidence to allow us to extract or infer the 
strength of these relationships. Furthermore, we 
know that risk factors often co-occur106 and, at least 
for dementia, there is a dose response with greater 
numbers of risk factors conferring higher levels of 
risk.14 In addition, neither the risk factors nor the 
outcomes are independent. For example, both 
stroke and diabetes increase risk of dementia and 
obesity raises risk of diabetes, high blood pressure 
and dementia.101,107 In fact, it is more likely that the 
true relationships are best represented as a web of 
influence with relationships within and between 
both risk factors and outcomes. These putative 
relationships now need to be clarified using high 
quality longitudinal participant level data. Suitable 
datasets should represent relevant global popula-
tions and have sufficiently long follow up to evalu-
ate confounded and competing relationships and to 
allow sufficient confidence about inferred causal 
relationships, thereby avoiding issues such as 
reverse causality.100 Further risk factors and out-
comes may exist beyond those examined here and 
these too need to be investigated.
Our review also noted age as a risk factor common 
to each of the NCDs. Although typically consid-
ered a nonmodifiable risk factor, the risk it con-
tributes varies between individuals. Variability in 
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the risk of death for people of the same age was 
labelled as ‘frailty’ in 1979.108 The concept was 
later generalized to describe variability in the risk 
of an adverse outcome for people with the same 
degree of exposure. It is commonly implemented 
as a term that accounts for unobserved random 
effect in proportional hazards models. As reviewed 
elsewhere, frailty is also operationalized as a clini-
cal syndrome or as a state.109 As noted there, in 
either guise, it is an important independent risk 
for common late-life illnesses, including heart 
disease, osteoporotic fracture and dementia. 
Recently, the degree of frailty was found to mod-
erate the relationship between neuropathologi-
cally defined AD and its clinical expression as 
dementia. Inasmuch as some degree of frailty may 
be modifiable, then understanding its role in dis-
ease is important. Further, understanding what it 
is about ageing that makes it such a common risk 
factor may lead to interventions that can reduce 
the burden of age.110
Wider context and the next steps
In this overview, we have highlighted the likely 
overlap between risk factors for NCDs and called 
for further work to quantify the strength and 
direction of the relationships between risk factors 
and incident NCDs. In addition, given the likely 
complexity of the associations, we have also high-
lighted the need to evaluate the relationships 
between the risk factors themselves and between 
the disease states. This is timely. The changing 
prevalence of NCD around the world makes fur-
ther understanding of these complex inter-rela-
tionships a priority. The WHO recorded the top 
two global causes of death in 2000 and 2016 as 
CHD and stroke, but by 2016, AD and other 
dementias and trachea bronchus and lung can-
cers were present. In wealthier countries in 2016, 
NCDs were even more strongly represented 
alongside CHD, stroke and DM in lower- 
middle- and low-income countries.18 Furthermore, 
research looking at population-attributable risk 
for established dementia risk factors reported the 
possibility of reducing dementia risk by up to 
28% (taking account of overlaps between risk fac-
tors), with some of the biggest drivers of increased 
risk identified as physical inactivity and smok-
ing.106 This analysis now needs to be extended to 
incorporate wider NCDs. Once we have clarified 
the strength of the relationships in the web of 
influence between the risk factors and disease 
states our next step must be to extend this to 
include population-attributable risk, design and 
evaluation of informed and targeted NCD risk 
reduction intervention and eventually, economic 
impact. The main NCDs and their risk factors are 
connected and prevalent; prevention is vital, but 
resources inevitably limited. An interactive eco-
nomic model, where we can explore and evaluate 
the impact of risk reduction strategies on multiple 
interacting disease states, would be an invaluable 
public health tool. Such a tool is currently con-
ceptual but represents a goal towards which all 
interested parties should be working.
In our high-level overview of the epidemiology we 
demonstrate the interconnected and overlapping 
relationships between common risk factors and 
common NCDs. Gaining a greater understanding 
and taking greater account of these relationships 
will facilitate more appropriate and targeted risk 
reduction, and this should now be our goal.
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